The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of consensus molecular subtypes (CMS) with time to progression (TTP), progression free survival (PFS), and overall survival (OS) with second-line FOLFIRI ± regorafenib in metastatic colorectal cancer (mCRC).
 
Michael Sangmin Lee
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - Amgen; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Pfizer
 
Sara R. Selitsky
No Relationships to Disclose
 
Joel S. Parker
No Relationships to Disclose
 
James Todd Auman
No Relationships to Disclose
 
Yunhan Wu
No Relationships to Disclose
 
Kelli Hammond
No Relationships to Disclose
 
Bert O'Neil
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Genentech/Roche; Merck
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Bayer; Merck KGaA
 
Hanna Kelly Sanoff
Research Funding - Bayer (Inst); Merck (Inst)
 
Federico Innocenti
Patents, Royalties, Other Intellectual Property - Royalties from the Mayo Foundation on the UGT1A1 testing